Last reviewed: June 17, 2026
Last updated: June 17, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide pens delivered through licensed compounding pharmacies contain enough medication for approximately four weekly injections per pen, making them cost-effective tools for weight loss therapy. Many patients new to injectable GLP-1 medications wonder whether their pens are disposable after one injection or whether they can safely use the same pen across multiple weeks. Proper injection practices directly impact both treatment outcomes and personal safety.
How Semaglutide Injection Pens Are Designed to Work
Semaglutide pens function as multi-dose delivery devices rather than single-use applicators. Each pen contains enough compounded semaglutide for four sequential weekly injections when dosed correctly, with the dosing dial allowing patients to select their prescribed amount before each use. The internal mechanism includes a sterile needle that retracts automatically after injection, protecting against accidental needle sticks and cross-contamination between doses.
The pharmaceutical design of semaglutide pens prioritizes convenience without sacrificing sterility. Patients attach a fresh sterile needle before each weekly injection, meaning only the needle changes—never the pen itself across its four-dose lifespan. This approach reduces waste, lowers treatment costs, and maintains the medication's stability throughout the prescription cycle when stored properly at controlled temperatures.
Single-Needle vs. Multi-Needle Injection Protocols
Using the same needle across multiple injections from one pen significantly increases infection risk and tissue damage. Needles become duller and less sterile after penetrating skin, which can cause bruising, bleeding, and bacterial entry at injection sites. Medical guidelines uniformly recommend attaching a new sterile needle immediately before each injection, regardless of whether the same pen is used across multiple weeks.
PlexusDx compounded semaglutide injections arrive with clear instructions specifying needle attachment before each dose. Patients who follow this single-needle-per-injection practice experience fewer localized reactions, reduced injection-site pain, and better long-term tolerability. Reusing needles also compromises the pen's internal mechanisms over time, potentially affecting dose accuracy in later injections from the same multi-dose pen.
Proper Storage and Pen Lifespan for Compounded Semaglutide
Compounded semaglutide from licensed 503A pharmacies maintains its stability and potency when stored between 36°F and 46°F (2°C to 8°C) in a standard refrigerator, similar to other injectable peptide therapies. Each pen remains viable for its full four-week dosing cycle as long as temperature control is maintained and the pen is protected from direct light. Patients should never freeze pens or leave them at room temperature for extended periods, as both conditions degrade the medication.
Once patients complete the four-week cycle with a multi-dose pen, they discard it and begin a fresh pen in week five. PlexusDx ensures continuous supply through coordinated monthly delivery, eliminating gaps in treatment and preventing inconsistent dosing patterns. Temperature-controlled storage is critical—patients traveling should use portable cooling packs or insulins travel cases to maintain the required refrigeration range throughout their therapy.
Injection Site Rotation and Safety Best Practices
Rotating injection sites across the abdomen, thighs, and upper arms reduces localized irritation, lipodystrophy (fatty tissue changes), and injection-site pain over time. Patients should select a new anatomical location each week, spacing injections at least one finger-width apart from previous puncture marks. This rotation strategy improves medication absorption consistency and prevents the development of scar tissue or hardened nodules that can interfere with future injections.
Safe injection practices extend beyond site selection to include proper cleaning and needle handling. Before each injection, patients should clean the injection area with an alcohol swab and allow it to air-dry for 30 seconds—inserting a needle into wet skin increases infection risk. After injecting, patients should never recap needles by hand; instead, they should dispose of used needles immediately in a sharps container. PlexusDx provides detailed injection instruction videos and written guides with each shipment to reinforce these safety fundamentals.
Why Compounded Semaglutide Pricing Remains Flat Across Dose Levels
PlexusDx compounded semaglutide injections start at $149 per month regardless of the dose level a patient requires, reflecting a commitment to transparent, predictable treatment costs. Unlike some weight loss programs that charge per-dose premiums as patients titrate upward, PlexusDx pricing remains consistent even when clinical response requires higher doses over time. This flat-rate model removes financial barriers to dose optimization and ensures patients never face unexpected cost increases as their therapy progresses.
Monthly pricing at PlexusDx includes access to licensed 503A compounding pharmacies, nationwide shipping to all 50 states, and HSA or FSA payment eligibility for patients with qualifying accounts. Patients receive their full month's supply of multi-dose pens, sterile needles, and comprehensive injection instructions without membership fees or insurance requirements. The Precision Peptide Genetic Test, available at $99 after the first month of treatment, helps identify which GLP-1 pathway variant best predicts individual treatment response—enabling truly personalized semaglutide protocols.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I use the same semaglutide pen for all four weekly injections?
Yes—each semaglutide pen contains medication for approximately four weekly doses. However, you must attach a fresh sterile needle before each injection; reusing the same needle increases infection risk and causes injection-site pain. PlexusDx supplies sterile needles with each monthly shipment so you can safely inject from one pen across four consecutive weeks.
How long does one semaglutide pen last, and when do I switch to a new pen?
Each multi-dose pen lasts approximately four weeks when injected once weekly at your prescribed dose. After your fourth injection from that pen, you discard it and begin a fresh pen the following week. PlexusDx coordinates monthly delivery so you never run out—your new pen arrives before you finish the previous one.
What is the cost difference between compounded semaglutide and other GLP-1 options?
PlexusDx compounded semaglutide injections start at $149 per month, making them one of the most accessible GLP-1 options available. Unlike flat per-compound pricing models, your monthly cost remains flat whether your doctor increases your dose during titration. Oral semaglutide begins at $249 per month if you prefer a non-injection format.
What happens if I accidentally reuse a needle or leave my pen unrefrigerated?
Reusing needles increases localized infection, bruising, and tissue damage at injection sites. Unrefrigerated pens may lose potency, reducing treatment effectiveness. If either occurs, contact PlexusDx support immediately—they can advise whether dose adjustments or early replacement are necessary to maintain your weight loss trajectory.
How can I know if semaglutide is the best GLP-1 for my genetic makeup?
PlexusDx offers the Precision Peptide Genetic Test ($99 after your first treatment month), which analyzes key variants like GLP1R rs6923761 and GIPR rs1800437 to predict your individual response to semaglutide versus tirzepatide. This peptide-pathway genetic insight helps personalize your therapy and optimize outcomes based on your unique biology.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Can You Take Wegovy with Methotrexate? Navigating Weight Loss and Complex Health Needs
Ozempic and Alcohol: Understanding How to Drink Responsibly on Your Weight Loss Journey